Your browser doesn't support javascript.
loading
Factors associated with intention for revaccination among patients with adverse events following immunization.
Muñoz, Caroline E; Pham-Huy, Anne; Pernica, Jeffrey M; Boucher, François D; De Serres, Gaston; Vaudry, Wendy; Constantinescu, Cora; Sadarangani, Manish; Bettinger, Julie A; Tapiéro, Bruce; Morris, Shaun K; McConnell, Athena; Noya, Francisco; Halperin, Scott A; Top, Karina A.
Afiliación
  • Muñoz CE; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Canadian Center for Vaccinology, IWK Health, Nova Scotia Health, and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Pham-Huy A; Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
  • Pernica JM; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Boucher FD; Centre hospitalier universitaire de Québec-Université Laval, Québec, Québec, Canada.
  • De Serres G; Centre hospitalier universitaire de Québec-Université Laval, Québec, Québec, Canada.
  • Vaudry W; Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
  • Constantinescu C; Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.
  • Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bettinger JA; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tapiéro B; Division of Infectious Diseases, CHU Sainte Justine, Université de Montréal, Montréal QC, Canada.
  • Morris SK; Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • McConnell A; Jim Pattison Children's Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Noya F; Division of Allergy and Immunology and Division of Infectious Diseases, Montreal Children's Hospital-McGill University Health Centre, Montreal, QC, Canada.
  • Halperin SA; Canadian Center for Vaccinology, IWK Health, Nova Scotia Health, and Dalhousie University, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Canada.
  • Top KA; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Canadian Center for Vaccinology, IWK Health, Nova Scotia Health, and Dalhousie University, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Canada. Electronic address: kt
Vaccine ; 41(42): 6239-6247, 2023 10 06.
Article en En | MEDLINE | ID: mdl-37666696
ABSTRACT

OBJECTIVES:

Individuals and healthcare providers may be uncertain about the safety of revaccination after an adverse event following immunization (AEFI). We identified factors associated with physician recommendation for revaccination and participant intention to be revaccinated among patients with adverse events following immunization (AEFIs) assessed in the Canadian Special Immunization Clinic (SIC) Network from 2013 to 2019.

METHODS:

This prospective observational study included patients assessed in the Canadian Special Immunization Clinic Network from 2013 to 2019 for an AEFI who required additional doses of the vaccine temporally associated with their AEFI. Participants underwent standardized assessment and data collection. Physician recommendations regarding revaccination and participant intent for revaccination were recorded. AEFI impact on daily activities and need for medical attention was captured as low, moderate, high impact and serious (e.g., requiring hospitalization). Multivariable logistic regression analysis identified factors associated with physician recommendation and participant intention for revaccination, controlling for province of assessment.

RESULTS:

Physician recommendation was significantly associated with the type of AEFI and AEFI impact. Compared to large local reaction, physician recommendation for revaccination was reduced for immediate hypersensitivity (aOR 0.24 [95% CI 0.08-0.76]) and new onset autoimmune disease (aOR 0.16; 95% CI 0.04-0.69). Compared to low impact AEFIs, physician recommendation was reduced for moderate (aOR 0.22 [95% CI 0.07-0.65]), high impact (aOR 0.08 [95% CI 0.02-0.30]), and serious AEFIs (aOR 0.11 [95% CI 0.03-0.37]). Participant intention for revaccination was significantly associated with AEFI impact, with reduced odds for high versus low impact AEFIs (aOR 0.12 [95% CI 0.04-0.42]).

CONCLUSION:

Physicians appear to use AEFI type and impact to guide recommendations while patients use primarily AEFI impact to form intentions for revaccination. The findings may help inform counselling for patients with AEFIs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / Inmunización / Intención Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / Inmunización / Intención Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Canadá
...